Economics and Mathematical Modeling in Health-Related Research

The definition of a healthcare system evolves continuously, becoming broader and more complex with each rendering. Healthcare systems can consist of many different elements, including but not limited to: access to comprehensive medical care, health promotion, disease prevention, institutional framework, financing schemes, government responsibility over health, etc. In light of its broad classification of healthcare, this book focuses on a wide spectrum of health-related issues ranging from risk factors for disease to medical treatment and possible frameworks for healthcare systems. Aging populations, increasing costs of healthcare, advancing technology, and challenges created by the COVID-19 pandemic require an innovative conceptual and methodological framework. By combining the experience and effort of researchers from a variety of fields including mathematics, medicine and economics, this book offers an interdisciplinary approach to studying health-related issues. It contributes to the existing literature by integrating the perspective of treatment with the economic determinants of health care outcomes, such as population density, access to financial resources and institutional frameworks. It also provides new evidence regarding the pharmaceutical industry including innovation, international trade and company performance.

Contributors are: Sayansk Da Silva, Joe Feinglass, Scott W. Hegerty, Joseph E. Hibdon, Jr, Arkadiusz Michał Kowalski, Małgorzata Stefania Lewandowska, Dawid Majcherek, Ewelina Nojszewska, Izabela Pruchnicka-Grabias, Agata Sielska and Julian Smółka.
Open Access
Download PDF

Prices from (excl. shipping):

Marzenna Anna Weresa, Ph.D., Professor of Economics, SGH Warsaw School of Economics, Director of the World Economy Research Institute, Poland.

Christina Ciecierski, Ph.D., Professor, Department of Economics, Northeastern Illinois University, Principal Investigator, Chicago Cancer Health Equity Collaborative (ChicagoCHEC), USA.

Lidia Filus, Ph.D., Professor and Chair of Mathematics, PI Chicago Cancer Health Equity Collaborative (ChicagoCHEC) Northeastern Illinois University, USA.
List of Figures and Tables

Marzenna Anna Weresa, Christina Ciecierski and Lidia Filus

PART 1: Modeling of Diseases’ Risk Factors: Implications for Patients’ Treatment

1 Racial, Ethnic and Socioeconomic Disparities in Lung and Breast Cancer Outcomes
Joe Feinglass

2 Reducing Cancer Mortality: A Cluster Analysis of Risk Factors for Lung Cancer across EU Countries
Dawid Majcherek, Marzenna Anna Weresa and Christina Ciecierski

3 Trends in Incidence of Zoonotic Foodborne Diseases in the United States in 2010–2019
Sayansk Da Silva and Joseph E. Hibdon, Jr.

PART 2: Determinants of Public Health Outcomes

4 Institutional Analysis of Healthcare Systems in Selected Developed Countries
Julian Smółka

5 Value Based Healthcare (VBHC) as a Tool for Achieving Clinical Effectiveness
Ewelina Nojszewska and Agata Sielska

6 Meeting Grand Challenges: Assessment of Horizon 2020 Health, Demographic Change and Wellbeing Projects
Małgorzata Stefania Lewandowska

7 Bank Density, Population Density, and Economic Deprivation across the United States: Implications for Public Health Outcomes
Scott W. Hegerty

PART 3: Pharmaceutical Industry: Innovation, Trade, and Company Performance

8 Healthcare Systems and Pharmaceutical Industry in Emerging and Developed Economies: China and Poland versus the US and the EU
Arkadiusz Michał Kowalski

9 Export Patterns in Medical Products in the Times of the Covid-19 Pandemic: Focus on Pharmaceuticals
Marzenna Anna Weresa

10 Pharmaceutical Companies as Portfolio Investments
Izabela Pruchnicka-Grabias

Marzenna Anna Weresa, Christina Ciecierski and Lidia Filus

This collection will appeal to a wide audience including academic libraries, researchers, medical practitioners and policy-makers involved in designing and implementing public health policy. The COVID-19 pandemic increased interests in public health issues. There is growing number of scholars, policymakers, businesses and healthcare organizations interested in the results of health research.
  • Collapse
  • Expand